News

When discussing the growing cost of drugs, we tend to frame the topic around name-brand versus generic drugs, with a view that despite the cost-saving opportunities of generics, overall spending on drugs continues to increase. However, segmenting the drug market into categories beyond purely brand versus generic drugs enables us to more accurately identify the major trends and drivers for drug prices in workers’ compensation.

This month, myMatrixx will be featured at two upcoming conferences: 2022 National Rx Drug Abuse & Heroin Summit and the AZ Self Insurers Virtual Seminar.

myMatrixx's parent organization Evernorth has released its Health Care in Focus 2022 Report that reveals key insights in the healthcare industry for driving change and action. The report includes key insights, statistics and more on mental health and telehealth, which are widespread discussion topics in the workers' comp industry.

Brian Williams, Clinical Account Executive, will represent myMatrixx at this year's "Speed-Dating with Risk & Insurance" conference which will be held in-person at the Tampa Bay History Center and hosted by The Defense Collaborative from Feb. 23-24, 2022. Williams will present on "Cannabis at Work" during the in-person conference.

Cliff Belliveau highlights innovation in workers’ compensation and key lessons we can adopt from other industries in a recent Workers’ Compensation Institute (WCI) weekly newsletter.

Hear from Mike Cirillo about how Kids' Chance unifies the workers' comp industry to make a difference.

Make sure to mark your calendar for this year's virtual event!

The myMatrixx clinical pharmacy team has released an updated version of their Position Paper regarding COVID-19 Vaccination, Treatment and Coverage under Workers’ Compensation.

The myMatrixx team is excited to attend in-person once again and will have our own thought leaders presenting!

Phil Walls and The Hartford's Dr. Seidner share effective strategies for decreasing drug reliance